Inhibitory Antibodies
抑制性抗体(Inhibitory Antibodies,常被称为中和抗体或阻断抗体)是一种能够特异性结合目标分子(如受体、酶或细胞因子),并直接抑制或阻断其正常生物学功能的特异性抗体。
| 货号 | 产品 | 反应 | 应用 | 偶联 | 引用 |
|---|---|---|---|---|---|
| BF6050 | Ifinatamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6051 | Burosumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6052 | Telisotuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6053 | Belimumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6054 | Ofatumumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6055 | Infliximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6056 | Rozanolixizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6057 | Gemtuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6058 | Spartalizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6059 | Cemiplimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6060 | Panitumumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6061 | Trastuzumab emtansine | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6062 | Tiragolumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6063 | Tremelimumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6064 | Mosunetuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6065 | Glofitamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6066 | Inebilizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6067 | Tafasitamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6068 | Emibetuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6069 | Onartuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6070 | Anetumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6071 | Evolocumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6072 | Bococizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6073 | Alirocumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6074 | Utomilumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6075 | Sibeprenlimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6076 | Aducanumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6077 | Enoblituzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6078 | Eculizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6079 | Girentuximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6080 | Plozalizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6081 | Mogamulizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6082 | Leronlimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6083 | Teplizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6084 | Ibalizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6085 | Felzartamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6086 | Isatuximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6087 | Alemtuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6088 | Polatuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6089 | Cibisatamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6090 | Labetuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6091 | Elotuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6092 | Emactuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6093 | Ulocuplumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6094 | Emicizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6095 | Abciximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6096 | Talquetamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6097 | Omalizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6098 | Canakinumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6099 | Bermekimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |